Clinical Trial Update: A Study of Avastin (Bevacizumab) in Combination With Taxane-based Chemotherapy as First Line Treatment in Patients With HER-2 Negative Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating bevacizumab (Avastin) with taxane-based chemotherapy as first-line treatment for HER2-negative breast cancer; results were posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Taxane-based chemotherapy

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-06-26